Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) Vol. 389; no. 10068; pp. 505 - 518
Main Authors: Henao-Restrepo, Ana Maria, Camacho, Anton, Longini, Ira M, Watson, Conall H, Edmunds, W John, Egger, Matthias, Carroll, Miles W, Dean, Natalie E, Diatta, Ibrahima, Doumbia, Moussa, Draguez, Bertrand, Duraffour, Sophie, Enwere, Godwin, Grais, Rebecca, Gunther, Stephan, Gsell, Pierre-Stéphane, Hossmann, Stefanie, Watle, Sara Viksmoen, Kondé, Mandy Kader, Kéïta, Sakoba, Kone, Souleymane, Kuisma, Eewa, Levine, Myron M, Mandal, Sema, Mauget, Thomas, Norheim, Gunnstein, Riveros, Ximena, Soumah, Aboubacar, Trelle, Sven, Vicari, Andrea S, Røttingen, John-Arne, Kieny, Marie-Paule
Format: Journal Article
Language:English
Published: England Elsevier Ltd 04.02.2017
Elsevier Limited
Elsevier
Subjects:
ISSN:0140-6736, 1474-547X, 1474-547X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first